Trial Profile
A Double-Blind Randomised Placebo-controlled Phase IIb Clinical Trial to Study the Efficacy & Safety of a Novel Platelet Lysate Gel in the Treatment of Lateral Epicondylitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Platelet-lysate-based-cell-therapy-Celixir (Primary)
- Indications Tennis elbow
- Focus Adverse reactions; Therapeutic Use
- Sponsors Celixir
- 13 Jun 2017 New trial record
- 30 Jun 2015 Accordign to the Celixir media release, the endpoints, Improvement in tendon injury, assessed with DASH (Disabilities of the Arm, Shoulder and Hand) PRTEE (Patient-Rated Tennis Elbow Evaluation) has been met.